Objective. To compare local infiltration of dexamethasone to intravenous injection for postoperative pain and recovery after tonsillectomy. Study Design. Prospective, randomized study. Setting. Second Affiliated Hospital of Harbin Medical University. Clinical trials registration number: ChiCTR-TRC-13003535.
Subjects and Methods. Children (n = 240, American Society of Anesthesiologists [ASA] classes I-II, aged 5-10 y) scheduled for tonsillectomy were randomly and equally assigned to 3 groups: DEX-IV, for intravenous injection of dexamethasone (0.5 mg/kg, maximum dose 24 mg); DEX-INF, given the same amount of dexamethasone by local infiltration to the upper middle and lower poles of the tonsils; and a control group not given dexamethasone. Postoperative pain was scored at intervals from 30 minutes to 24 hours. The time to first administration of analgesic and average consumption of analgesic, times to first oral water and solid food intake, and incidence rates of nausea and vomiting were evaluated.
Results. From postoperative 1 to 16 hours, the DEX-INF group had significantly lower pain scores than did the DEX-IV group, and the time to first analgesic and average consumption of analgesic were also significantly lower. The times to first oral water and food intake in the DEX-INF group were significantly shorter than in the DEX-IV group. The incidence of nausea and vomiting in the DEX-INF group was higher than that of the DEX-IV group.
Conclusion. Local infiltration of dexamethasone was more effective than systemic administration to decrease pain and time to food intake, but the antiemetic effect was less.
T onsillectomy is a common surgery performed in the pediatric population. [1] [2] [3] The procedure can lead to significant postoperative pain due to trauma of the oropharynx and tonsillar fossae and irritation of nerve endings. Nausea, vomiting, and pain can delay postoperative oral fluid intake and feeding, thus prolonging hospitalization and increasing dehydration risk. 4 Both systemic administration of dexamethasone [5] [6] [7] [8] [9] [10] [11] and local infiltration 12, 13 can reduce postoperative pain scores and average consumption of analgesics, as well as treat postoperative nausea and vomiting. However, to our knowledge, no study has compared the outcomes of local infiltration dexamethasone with those of systemic dexamethasone after tonsillectomy in children.
Single systemic injection of dexamethasone has shortcomings that include wide distribution and short acting time, and its effect at the site of trauma is less than optimal. Grossi et al 14 proposed that injection of low-dose dexamethasone at the surgical site may achieve a higher localized effective drug concentration without loss due to distribution or the onset of elimination. In the present study, we hypothesized that local infiltration of dexamethasone may be more effective for children undergoing tonsillectomy. The present trial was conducted to evaluate local infiltration of dexamethasone relative to systemic administration with regard to postoperative pain and recovery after tonsillectomy in children.
and Anesthesia at the Second Affiliated Hospital of Harbin Medical University. Parents of the patients provided written informed consent for participation in the study.
The subjects of the study consisted of 240 children (American Society of Anesthesiologists [ASA] classes I-II, aged 5-10 y) scheduled for tonsillectomy. Exclusion criteria were white blood cells .12 3 10 9 or \4 3 10 9 , bronchial asthma, adenoids, congenital heart disease, electrolyte abnormalities, liver or kidney disease, peritonsillar abscess, or coagulation disorder. The random assignment of children was conducted using a randomized number table and sealed in an envelope. The first anesthesiologist who prepared the drugs for local infiltration or intravenous injection knew the allocation of the children. The second anesthesiologist administered the anesthesia and dexamethasone or saline injection. The same surgical team performed the local infiltration and surgery. The third anesthesiologist visited the children and recorded the postsurgical pain scores, side effects, and complications.
All the children were forbidden solid food for 6 hours and water for 4 hours prior to surgery. Thirty minutes before induction, 0.5 mg/kg midazolam and 0.02 mg/kg atropine were given by oral route. After transfer to the operating room, heart rate, mean arterial pressure (MAP), and oxygen saturation (SpO 2 ) were continuously monitored. Anesthesia was induced by 2 mg/kg propofol, 0.4 mg/kg atracurium, and 4 mg/kg fentanyl. Anesthesia was maintained with sevoflurane (1.5%) and remifentanil (0.17 mgÁkg 21 Ámin 21 ).
The 240 children were randomized into a control group, a dexamethasone intravenous injection group (DEX-IV), or a dexamethasone local infiltration group (DEX-INF) by the first anesthesiologist. The tidal volume was set at 8 mL/kg and the respiratory rate at 14 to 16 per minute to maintain an end-tidal carbon dioxide partial pressure of 30 to 40 mm Hg. Mean arterial pressure and heart rate were maintained within 20% of baseline values with sevoflurane, ephedrine, and atropine. All children were placed in the Rose position, and a mouth gag was inserted into the mouth.
Prior to the operation, the children in the DEX-INF group received local infiltration of 0.5 mg/kg dexamethasone (maximum dose 24 mg) diluted in 10 mL saline and intravenous injection of 10 mL saline. The children in the DEX-IV group received local infiltration of 10 mL saline and intravenous injection of 0.5 mg/kg dexamethasone (maximum dose 24 mg). The children in the control group did not receive dexamethasone. The dexamethasone for infiltration or intravenous injection was prepared according to the weight of each child by the first anesthesiologist in a separate operating room. The dexamethasone or saline was infiltrated to the upper middle and lower poles of the tonsils with a 24-gauge needle by the same surgeon who was blinded to the assignment.
Five minutes after local infiltration or intravenous injection, the tonsillectomies (performed with a sharp dissection technique with cautery hemostasis) were performed by the same surgeon, with the assistance of the same surgical team. After the operation and withdrawal of anesthetics, the residual neuromuscular blockade was antagonized with 0.01 mg/kg atropine and 0.05 mg/kg neostigmine. The tracheal extubation was performed when the child had a regular respiratory pattern and recovery of gag reflex and could maintain SpO 2 .95% for 5 minutes with air. The duration of the operation and anesthesia, as well as the volume of bleeding and infusion, were recorded. After extubation, each child was transferred to the postanesthesia care unit (PACU), and MAP, heart rate, and SpO 2 were monitored. The children were discharged from the PACU if they could maintain SpO 2 .95% with air. Heart rate, MAP, and SpO 2 were continuously monitored for 4 hours in the ward. The third anesthesiologist visited the children in the ward and recorded the score of each child's pain according to the modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS; Table 1 ). 15 If the children felt pain at times other than the visited time points, the parents evaluated the pain score. If the parents reported a pain score higher than 4, the third anesthesiologist went to the ward immediately and assessed the pain score. If the mCHEOPS was more than 4 evaluated by the anesthesiologist, 1 mg/kg fentanyl was intravenously injected, oxygen inhalation through a nasal catheter was administered, and SpO 2 was monitored for 1 hour to prevent respiratory depression.
In this study, the postoperative mCHEOPS score was the primary outcome. Secondary outcomes included the time to first requirement of fentanyl, average fentanyl consumption, incidences of nausea and vomiting, time to first oral intake of water, and time to solid food oral intake. The mCHEOPS score was recorded at 30 minutes and 1, 4, 8, 16, and 24 hours after surgery. The time from discharge from the PACU to the first administration of fentanyl and average consumption of fentanyl were recorded, as well as the time from discharge from the PACU to first oral intake of water and first solid food. Nausea and vomiting events were recorded by a nurse who was trained to distinguish objectively nausea from other postoperative symptoms and was blinded to the study conditions. To guarantee objectivity, the nurse did not participate in this trial. If vomiting occurred more than twice in 2 minutes, 0.15 mg/kg metoclopramide was intravenously injected by the same nurse. Postoperative complications included bleeding, fever, flushing, or headache.
Ethics
Ethical approval for this study (Ethical Committee: HMUIRB- 
Statistical Analyses
The sample size calculation was based on a previous study. 10 The sample size calculation, which used a 2-sided design at a significance level of 5% (a = 0.05) and a power of 80% (1 -b = 0.8), indicated that 74 patients per group would be needed to detect a 1-point decrease in mCHEOPS score. To allow for lack of eligibility and attrition, 80 patients per group were enrolled in this study.
All the data were analyzed using SPSS software (version 11.5; SPSS, Inc, an IBM Company, Chicago, Illinois). The demographic characteristics, duration of anesthesia and surgery, and adverse events were compared using the Student t test or x 2 test. The pain scores were analyzed by repeatedmeasures analysis of variance (ANOVA) with post hoc Bonferroni correction. Average consumption of fentanyl, time to first use of fentanyl, and first oral intake were analyzed using the Student t test if the data were normally distributed or the Mann-Whitney U test if the data were not normally distributed. Nausea and vomiting rates were evaluated using the x 2 test. The P value of difference between 2 groups was adjusted to .0167.
Results
No child was excluded during selection for this study (Figure 1) . Five children were excluded because of bleeding that required intervention (1 in the control group and 2 each in the DEX-IV and DEX-INF groups). There were no significant differences among the groups with regard to age, sex, or weight; duration of anesthesia and surgery; volume of infusion; or complications (P . .05; Table 2 ). No patients experienced delayed discharge or readmission for pain control or nausea or vomiting. Administration of dexamethasone (DEX-INF and DEX-IV) was associated with significantly lower postoperative mCHEOPS scores, relative to the scores of the control group (Figure 2 and Table 3 ). Furthermore, the mCHEOPS scores of the children in the DEX-INF group were significantly lower than the scores of the DEX-IV group, from 1 to 16 hours after surgery (P \ .001).
Administration of dexamethasone (DEX-INF and DEX-IV) was associated with significantly longer time to first administration of fentanyl and less average consumption of fentanyl compared with the control group ( Table 4) . Sixty children in the control group, 44 children in the DEX-IV group, and 32 children in the DEX-INF group were administered injected fentanyl to reduce postoperative pain. Seventeen children in the control group and 9 children in the DEX-IV group were administered injected fentanyl twice. No child in the DEX-INF group required a second injection of fentanyl. Time to the first administration of fentanyl in the DEX-INF group was significantly longer than this time in the DEX-IV group, and fentanyl consumption was significantly less.
Compared with the control group, children who received dexamethasone (groups DEX-INF and DEX-IV) required significantly less time to their first oral intake of fluid and solid food, and fewer children needed metoclopramide ( Table 4 ). The times to first oral intake of fluid and solid food were significantly shorter in the DEX-INF group than in the DEX-IV group. Although the incidence of nausea and vomiting in the DEX-IV group was lower than that of the DEX-INF group, the difference was not statistically significant. The number of children who needed metoclopramide in the DEX-IV group was significant lower than in the DEX-INF group.
No adverse side effects due to dexamethasone occurred in this study.
Discussion
In this study, we evaluated the postoperative effects of local infiltration of dexamethasone relative to those of conventional systemic (intravenous) dexamethasone administered to children prior to tonsillectomy. We found that, compared with children given systemic dexamethasone, local dexamethasone infiltration was associated with significantly less postoperative pain, longer time to fentanyl requirement, decreased average consumption of fentanyl, and less time to first food oral intake. Tonsillectomy can result in local tissue trauma and edema, pain, nausea, and vomiting. 16 Postoperative pain, nausea, vomiting, and delayed oral intake can result in dehydration, prolong hospitalization, and even lead to a 14% hospital readmission rate. 17 Either systemic or locally administrated dexamethasone can reduce postoperative pain and improve recovery after tonsillectomy. [5] [6] [7] [8] [9] [10] [11] [12] [13] However, at the site of trauma, systemic dexamethasone may be less effective than local infiltration. With regard to differences in absorption, distribution, half-life, and target site of dexamethasone that are related to different methods of administration, 18 we hypothesized that local infiltration around the surgical site may provide a repository effect that would slow absorption and better prolong the duration of action relative to that of intravenous injection. 19 On the basis of results of previous studies, 10,20-23 we administrated 0.5 mg/kg dexamethasone either by local infiltration or intravenous injection 5 minutes prior to the tonsillectomy.
Significant improvements in pain, time to first use of fentanyl, and average consumption of fentanyl were noted in the children given local dexamethasone infiltration relative to those given the drug systemically. These results may be associated with differences in the absorption, distribution, and metabolism of dexamethasone of the different administration pathways. 19 Local infiltration of dexamethasone affects the impaired tissue more directly, delays dexamethasone absorption, and extends the effective time of analgesia in local tissue. 18 Locally infiltrated dexamethasone can decrease proinflammatory factors and cytokine production in impaired tissue via lipocortin 1, a glucocorticoidinducible protein that has been identified as a potential endogenous mediator of the anti-inflammatory activities of glucocorticoids. 24 This then reduces local edema and decreases pain at the surgical site. Furthermore, plasma dexamethasone absorbed from local tissue can also relieve pain by inhibiting phospholipase enzyme. 25, 26 Elhakim et al, 27 in accord with our previous study, 12 indicated that dexamethasone can improve the quality of postoperative oral intake. In the present study, our results imply that infiltrated dexamethasone can shorten the time to the first oral water and solid food intake, compared with dexamethasone intravenous injection. The improvement in time to oral intake by local infiltrated dexamethasone may be attributed to its reduction of pharynx edema and surgical pain.
Dexamethasone can decrease the incidence of postoperative nausea and vomiting after tonsillectomy 5-11 because of its direct inhibition of prostaglandins, serotonin, or endorphin production. 23, 27 In the present study, although we found that the incidence of nausea and vomiting was decreased by dexamethasone in the 2 groups that received dexamethasone, the difference was not statistically significant. Moreover, the incidence of nausea and vomiting was less in children given intravenous dexamethasone compared with those administered local infiltration. With infiltration, it is likely that the plasma dexamethasone concentration is less and therefore there is less systemic inhibition of prostaglandins, serotonin, or endorphin production. Although better analgesia and oral intake were associated with local infiltration, intravenous injection resulted in a better antiemetic effect.
Limitation of This Study
The original study design included a plan to detect the plasma concentrations of dexamethasone, to evaluate better the differences associated with local and systemic pathways. Unfortunately, not enough of the parents of the children were willing to authorize collection of peripheral blood for the purposes of the study, and this prevented us from conducting this analysis. Although the dexamethasone significantly reduced the mCHEOPS score after tonsillectomy, this difference lacked clinical significance at mCHEOPS scores less than 4. However, we used fentanyl to reduce postoperative pain, and the fentanyl may have influenced the incidence of postoperative nausea and vomiting. Values are presented as mean 6 SD unless otherwise indicated.
